Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Jul 31, 2007

Laureate to Manufacture Enobia Pharma’s Candidate against Hypophosphatasia

  • Laureate Pharma entered into a cGMP contract manufacturing agreement with Enobia Pharma, which is engaged in the development of enzyme replacement therapy for the treatment of hypophosphatasia.

    Laureate will produce Enobia Pharma’s fusion protein for this rare and sometimes fatal metabolic bone disease characterized by skeletal hypomineralization. Enobia anticipates initiating clinical studies in this lead program  in the summer of 2008.



Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »